Alphatec HoldingsATEC
ATEC
About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Employees: 839
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
48% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 58
1% less funds holding
Funds holding: 216 [Q2] → 214 (-2) [Q3]
2% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 44
7.96% less ownership
Funds ownership: 69.88% [Q2] → 61.92% (-7.96%) [Q3]
53% less capital invested
Capital invested by funds: $1.02B [Q2] → $483M (-$538M) [Q3]
53% less call options, than puts
Call options by funds: $2.64M | Put options by funds: $5.61M
100% less funds holding in top 10
Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$16
38%
upside
Avg. target
$18.67
61%
upside
High target
$20
73%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Sean Lee 57% 1-year accuracy 13 / 23 met price target | 73%upside $20 | Buy Reiterated | 14 Jan 2025 |
Needham David Saxon 34% 1-year accuracy 21 / 62 met price target | 38%upside $16 | Buy Maintained | 13 Jan 2025 |
Barclays Matt Miksic 67% 1-year accuracy 24 / 36 met price target | 73%upside $20 | Overweight Maintained | 19 Nov 2024 |
Financial journalist opinion
Based on 3 articles about ATEC published over the past 30 days
Positive
Zacks Investment Research
6 days ago
Alphatec (ATEC) Moves 9.1% Higher: Will This Strength Last?
Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Positive
Zacks Investment Research
1 week ago
Wall Street Analysts Predict a 73.42% Upside in Alphatec (ATEC): Here's What You Should Know
The consensus price target hints at a 73.4% upside potential for Alphatec (ATEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Neutral
Business Wire
1 week ago
ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2024. The Company also provided a financial outlook for full-year 2025. Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue Ranges Fourth Quarter Ended December 31, 2024 Full-Year Ended December 31, 2024 Surgical.
Neutral
Business Wire
1 month ago
ATEC to Present at the 2025 J.P. Morgan Healthcare Conference
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA, at 5:15pm PT on January 15, 2025. The webcast and the presentation materials will be available on the Investor Relations Section of the Company's website. About ATEC ATEC, through its wholl.
Neutral
Business Wire
2 months ago
ATEC to Participate in Upcoming Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Stifel Healthcare Conference at the Lotte New York Palace Hotel in New York, NY, on November 18, 2024, with a fireside chat at 3:35pm ET The Jefferies London Healthcare Conference at the Waldorf Hilton in Aldwych, London, on November 20,.
Neutral
Seeking Alpha
2 months ago
Alphatec Holdings, Inc. (ATEC) Q3 2024 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Mathew Blackman - Stifel Matt Miksic - Barclays Matthew O'Brien - Piper Sandler Caitlin Cronin - Cannacord David Saxon - Needham Sean Lee - H.C. Wainwright Drew Ranieri - Morgan Stanley Operator Good afternoon, everyone.
Negative
Zacks Investment Research
2 months ago
Alphatec (ATEC) Reports Q3 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.35 per share a year ago.
Neutral
Business Wire
2 months ago
ATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2024, and recent corporate highlights. Third Quarter 2024 Financial Results Quarter Ended September 30, 2024 Total revenue $151 million GAAP gross margin 68% Non-GAAP gross margin 69% GAAP operating expenses $136 million Non-GAAP operating expenses $114 mil.
Neutral
Business Wire
3 months ago
ATEC to Report Third Quarter Financial Results on October 30, 2024
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the.
Positive
Zacks Investment Research
3 months ago
3 Best Earnings Acceleration Stocks to Buy in a Strong Q4
With the advent of a strong fourth quarter, it's prudent to invest in stocks exhibiting solid earnings acceleration such as Argenx, Alphatec Holdings and Olin Corporation.
Charts implemented using Lightweight Charts™